Screening for early onset neonatal sepsis: NICE guidance-based practice versus projected application of the Kaiser Permanente sepsis risk calculator in the UK population.


Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 02 01 2019
revised: 24 06 2019
accepted: 01 07 2019
pubmed: 13 7 2019
medline: 10 3 2020
entrez: 13 7 2019
Statut: ppublish

Résumé

To compare management recommendations of the National Institute for Health and Care Excellence (NICE) guidelines with the Kaiser Permanente sepsis risk calculator (SRC) for risk of early onset neonatal sepsis (EONS). Multicentre prospective observational projection study. Eight maternity hospitals in Wales, UK. All live births ≥34 weeks gestation over a 3-month period (February-April 2018). Demographics, maternal and infant risk factors, infant's clinical status, antibiotic usage and blood culture results from first 72 hours of birth were collected. Infants were managed using NICE recommendations and decisions compared with that projected by SRC. Proportion of infants recommended for antibiotics on either tool. Of 4992 eligible infants, complete data were available for 3593 (71.9%). Of these, 576 (16%) were started on antibiotics as per NICE recommendations compared with 156 (4.3%) projected by the SRC, a relative reduction of 74%. Of the 426 infants avoiding antibiotics, SRC assigned 314 (54.6%) to normal care only. There were seven positive blood cultures-three infants were recommended antibiotics by both, three were not identified in the asymptomatic stage by either; one was a contaminant. No EONS-related readmission was reported. The judicious adoption of SRC in UK clinical practice for screening and management of EONS could potentially reduce interventions and antibiotic usage in three out of four term or near-term infants and promote earlier discharge from hospital in >50%. We did not identify any EONS case missed by SRC when compared with NICE. These results have significant implications for healthcare resources.

Identifiants

pubmed: 31296696
pii: archdischild-2018-316777
doi: 10.1136/archdischild-2018-316777
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-122

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Nitin Goel (N)

Neonatal Medicine, Singleton Hospital, Swansea, UK.
Neonatal Medicine, University Hospital of Wales, Cardiff, UK.

Sudeep Shrestha (S)

Neonatal Medicine, Royal Gwent Hospital, Newport, UK.

Rhian Smith (R)

Neonatal Medicine, Glan Clwyd Hospital, Rhyl, UK.

Akshay Mehta (A)

Neonatal Medicine, Singleton Hospital, Swansea, UK.

Malini Ketty (M)

Neonatal Medicine, University Hospital of Wales, Cardiff, UK.

Helen Muxworthy (H)

Women's Health, Singleton Hospital, Swansea, UK.

Artur Abelian (A)

Paediatrics, Wrexham Maelor Hospital, Wrexham, UK.

Vickness Kirupaalar (V)

Paediatrics, Princess of Wales Hospital, Bridgend, UK.

Shakir Saeed (S)

Paediatrics, Ysbyty Gwynedd, Bangor, UK.

Shikha Jain (S)

Paediatrics, Princess of Wales Hospital, Bridgend, UK.

Amar Asokkumar (A)

Neonatal Medicine, University Hospital of Wales, Cardiff, UK.

Murali Natti (M)

Neonatal Medicine, Royal Gwent Hospital, Newport, UK.

Ian Barnard (I)

Neonatal Medicine, Glan Clwyd Hospital, Rhyl, UK.

Prem Kumar Pitchaikani (PK)

Paediatrics, Glangwili General Hospital, Carmarthen, UK.

Sujoy Banerjee (S)

Neonatal Medicine, Singleton Hospital, Swansea, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH